Literature DB >> 24931250

Uterine artery embolization in cesarean scar pregnancy: safe and effective intervention.

Shasha Cao1, Lihong Zhu2, Long Jin3, Jian Gao1, Chen Chen1.   

Abstract

BACKGROUND: Cesarean scar pregnancy (CSP) is a very rare but life-threatening entity and there is no optimal management strategy. Here we report a successfully conservative treatment of CSP.
METHODS: We retrospectively analyzed the clinical data of 54 women with CSP, who underwent uterine artery embolization between January 2007 and September 2012 at the Peking University People's Hospital. We evaluated the clinical outcomes, the technique and the complications of uterine artery embolization.
RESULTS: Of the 54 patients, 2 patients with hemorrhage after induced abortion received bilateral uterine artery embolization treatment alone, and 52 patients underwent suction curettage after bilateral uterine artery embolization. All 54 women were successfully cured, without any severe complications, and uterine function was restored. During the follow-up, one patient had accidental normal interuterine pregnancy and received induced abortion during the first trimester.
CONCLUSION: [corrected] Uterine artery embolization combined with suction curettage is an effective and safe conservative treatment for cesarean scar pregnancy.

Entities:  

Mesh:

Year:  2014        PMID: 24931250

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

1.  The effect of prophylactic uterine artery embolization on reproductive outcomes in patients with cesarean scar pregnancy: a propensity score-matched study.

Authors:  Jiao Wang; Dandan Wang; Xinyue Zhang; Yuting Liu; Qing Yang; Ningning Zhang
Journal:  Arch Gynecol Obstet       Date:  2021-11-30       Impact factor: 2.344

2.  Cesarean Scar Pregnancy Treated by Artery Embolization Combined with Diode Laser: A Novel Approach for a Rare Disease.

Authors:  Felice Sorrentino; Vincenzo De Feo; Guglielmo Stabile; Raffaele Tinelli; Maurizio Nicola D'Alterio; Giuseppe Ricci; Stefano Angioni; Luigi Nappi
Journal:  Medicina (Kaunas)       Date:  2021-04-23       Impact factor: 2.430

3.  Management for delayed diagnosis in cesarean scar pregnancy with hemorrhage intra- or postuterine dilation and curettage.

Authors:  Xuetang Mo; Shiyan Tang; Cuilan Li
Journal:  J Obstet Gynaecol Res       Date:  2021-03-28       Impact factor: 1.730

4.  High-intensity focused ultrasound combined with suction curettage for the treatment of cesarean scar pregnancy.

Authors:  Xiaogang Zhu; Xinliang Deng; Yajun Wan; Songshu Xiao; Jiping Huang; Lian Zhang; Min Xue
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

5.  Bronchial artery embolization for hemoptysis: a retrospective observational study of 344 patients.

Authors:  Hongxia Shao; Junping Wu; Qi Wu; Xin Sun; Li Li; Zhiheng Xing; Hongfen Sun
Journal:  Chin Med J (Engl)       Date:  2015-01-05       Impact factor: 2.628

6.  Uterine Artery Rupture After Induced Abortion and Extraction of an Intrauterine Device.

Authors:  Xiao-Ming Yu; Jing Guan; Ting-Ting Sun
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

7.  Clinical Efficacy and Safety of Uterine Artery Embolization (UAE) versus Laparoscopic Cesarean Scar Pregnancy Debridement Surgery (LCSPDS) in Treatment of Cesarean Scar Pregnancy.

Authors:  Junhong Guo; Jiangtao Yu; Qing Zhang; Xiaojie Song
Journal:  Med Sci Monit       Date:  2018-07-06

8.  Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy.

Authors:  Feng Cheng; Dan Shan; Sijia Guo; Shuang Cheng; Hongwei Yang; Jialin Han; Tongxiu Hu
Journal:  Curr Mol Med       Date:  2019       Impact factor: 2.222

9.  Analysis on clinical effects of dilation and curettage guided by ultrasonography versus hysteroscopy after uterine artery embolization in the treatment of cesarean scar pregnancy.

Authors:  Jian Qiu; Yunfeng Fu; Jiewei Xu; Xiaohong Huang; Guorong Yao; Weiguo Lu
Journal:  Ther Clin Risk Manag       Date:  2019-01-07       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.